
The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.
Valeant shares are now down 70% year to date, and we still think they have even more room to fall.
By Diane Alter, Contributing Writer, Money Morning -
The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.
Valeant shares are now down 70% year to date, and we still think they have even more room to fall.
Here's what you need to know about the VRX stock price today, and what's next for the company.
By Diane Alter, Contributing Writer, Money Morning -
The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.
Valeant shares are now down 70% year to date, and we still think they have even more room to fall.
Here's what you need to know about the VRX stock price today, and what's next for the company.
By Diane Alter, Contributing Writer, Money Morning -
The Valeant stock price tanked 7% Monday and fell further today as things keep getting worse for the embattled drug company.
We called the Valeant stock price plunge last summer and remain bearish on the VRX stock price in 2016.
Here's what caused the latest rout, which backs our cautious stance...
By Diane Alter, Contributing Writer, Money Morning -
The VRX stock price soared 15% to $29.91 today after the embattled drug company said no additional restatements are necessary after an internal audit.
The company now is facing anxious creditors of its $11 billion secured loans.
Valeant's woes are far from over...
By Jack Delaney, Sr. Cannabis Editor, Money Morning -
The VRX stock price has plummeted 82% in the last six months because of predatory business practices.
Money Morning has covered the fall of Valeant Pharmaceuticals since October 2015, and our readers have made a profit of 700%.
By Diane Alter, Contributing Writer, Money Morning -
It has been an incredibly volatile day for the Valeant stock price. VRX stock jumped more than 15% to $31.59 this morning (Monday) after the pharmaceutical giant announced sweeping changes to its board.
Valeant Pharmaceutics Internationa Inc. (NYSE: VRX) shares were briefly halted after the news broke. When trading resumed, Valeant stock plunged. Ten minutes into today's session, the Valeant stock price was down 1% to a new 52-week low of $26.
Here's what is next for Valeant stock in 2016...
By Diane Alter, Contributing Writer, Money Morning -
The Valeant stock price has crashed 88% over the last six months, and the stock shows no sign of recovering.
And while many investors were crushed by the loss -- including famed activist Bill Ackman, who reportedly lost $1 billion on the stock - our readers made a profit of 700%.
By Diane Alter, Contributing Writer, Money Morning -
The Valeant stock price crashed nearly 39% today (Tuesday) to $40.00 after the company reported dismal earnings and weak guidance for 2016.
By Jack Delaney, Sr. Cannabis Editor, Money Morning -
Valeant not only missed expectations in its Q4 2015 earnings report, but also provided a bleak outlook for 2016.
The drug maker has dealt with countless scandals over the past six months, which has made the Valeant stock price plunge over 78% from its 52-week high of $263.81.
By Diane Alter, Contributing Writer, Money Morning -
The Valeant stock price is in free fall. Valeant stock tumbled another 8% to $59.88 today (Tuesday) after crashing 18% Monday following reports that the beleaguered company is under investigation by the U.S. Securities and Exchange Commission (SEC).
By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 -
The VRX stock price saw one of its worst single-day performances of the year yesterday.
Shares plunged after CEO J. Michael Pearson took a medical leave of absence due to pneumonia.
Now investors are wondering if the stock is bottoming out and ready to move higher in 2016...
By Money Morning Staff Reports, Money Morning -
Our "most hated companies 2015" list includes five companies that stole, poisoned, and defrauded their way to profits this year - and did so unapologetically.
Have a look at what these loathsome companies accomplished in 12 short months...
By Diane Alter, Contributing Writer, Money Morning -
The Valeant Pharmaceutical International Inc. (NYSE: VRX) stock price has come under pressure yet again this week following a new downgrade and significantly lowered company guidance.
Late last week, Valeant lowered its Q4 outlook and guided Q1 fiscal 2016 sales and earnings below Wall Street estimates.
Here's why we see the VRX stock price drop continuing into 2016...
By Money Morning Staff Reports, Money Morning -
Four of the most outrageous drug price increases in 2015 were born purely of greed...
Most of us have heard about Turing Pharmaceutical's CEO Martin Shkreli's infamous price-gouging incident.
But check out our chart to see four drug price hikes that were even more massive this year...
By Michael A. Robinson, Defense + Tech Specialist, Money Morning • @Robinson_STI -
There's been a ton of online chatter claiming that Valeant stock has become a screaming bargain.
And sure, it sounds like a bottom-feeder's dream come true. Since its Aug. 5 high, Valeant stock has dropped more than 65%. If it regained just 69% of its previous high, it would double.
But don't believe the hype. This is a deeply troubled company you should stay well away from.
Let me show you why you'll be glad you avoided this company at all costs...
By Diane Alter, Contributing Writer, Money Morning -
The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price has dropped 44% year to date and nearly 80% over the last three months.
While some are saying VRX stock has now become undervalued, Money Morning Global Credit Strategist Michael Lewitt says the Valeant stock price will only continue to fall.